Skandinaviska Enskilda Banken AB publ Sells 19,758 Shares of Cigna Group $CI

Skandinaviska Enskilda Banken AB publ cut its stake in shares of Cigna Group (NYSE:CIFree Report) by 8.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 208,558 shares of the health services provider’s stock after selling 19,758 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Cigna Group were worth $60,117,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of CI. Glenview Trust Co lifted its position in Cigna Group by 4.0% in the third quarter. Glenview Trust Co now owns 17,939 shares of the health services provider’s stock worth $5,171,000 after buying an additional 686 shares during the last quarter. denkapparat Operations GmbH lifted its holdings in shares of Cigna Group by 31.9% in the 3rd quarter. denkapparat Operations GmbH now owns 2,546 shares of the health services provider’s stock worth $734,000 after acquiring an additional 616 shares during the last quarter. Zions Bancorporation National Association UT lifted its holdings in shares of Cigna Group by 5.6% in the 3rd quarter. Zions Bancorporation National Association UT now owns 1,113 shares of the health services provider’s stock worth $321,000 after acquiring an additional 59 shares during the last quarter. State of New Jersey Common Pension Fund D boosted its stake in shares of Cigna Group by 2.1% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 93,235 shares of the health services provider’s stock worth $26,875,000 after purchasing an additional 1,877 shares during the period. Finally, GF Fund Management CO. LTD. grew its holdings in Cigna Group by 3.2% during the 3rd quarter. GF Fund Management CO. LTD. now owns 7,387 shares of the health services provider’s stock valued at $2,129,000 after purchasing an additional 228 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CI. Barclays decreased their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research note on Friday, February 6th. The Goldman Sachs Group decreased their price target on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Guggenheim restated a “buy” rating and set a $318.00 price objective on shares of Cigna Group in a report on Monday, February 2nd. Wells Fargo & Company cut their price objective on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research report on Wednesday, November 5th. Finally, Truist Financial set a $338.00 target price on Cigna Group in a research report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average target price of $330.00.

Get Our Latest Stock Report on Cigna Group

Cigna Group Trading Up 1.3%

CI opened at $291.35 on Tuesday. The company has a quick ratio of 0.76, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The stock’s fifty day moving average is $277.40 and its two-hundred day moving average is $283.75. The company has a market capitalization of $77.83 billion, a P/E ratio of 13.14, a PEG ratio of 1.01 and a beta of 0.27. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s payout ratio is 27.23%.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.